tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katie Tryhane, 6 are a BUY (75%), 2 are a SELL (25%).
Analyst Katie Tryhane, carries an average stock price target met ratio of 40% that have a potential upside of 11.41% achieved within 44 days.
Katie Tryhane’s has documented 16 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Aug-2022.
Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGS ) at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$32.97 (19.74%)
$180
11 days ago
(03-Oct-2025)
4/8 (50%)
$22.67 (12.78%)
86
Buy
$195
$27.97 (16.75%)
$165
12 days ago
(02-Oct-2025)
6/7 (85.71%)
$19.64 (11.20%)
54
Buy
$195
$27.97 (16.75%)
$203
1 months 5 days ago
(09-Sep-2025)
12/15 (80%)
$37.62 (23.90%)
94
Hold
$160
$-7.03 (-4.21%)
$165
2 months 7 days ago
(07-Aug-2025)
4/4 (100%)
$10.22 (6.82%)
17
$168
$0.97 (0.58%)
$220
5 months 2 days ago
(12-May-2025)
8/10 (80%)
$24.92 (17.42%)
95
What Year was the first public recommendation made by Katie Tryhane?
